Free-water imaging of the hippocampus is a sensitive marker of Alzheimer's disease
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Validating sensitive markers of hippocampal degeneration is fundamental for understanding neurodegenerative conditions such as Alzheimer's disease. In this paper, we test the hypothesis that free-water in the hippocampus will be more sensitive to early stages of cognitive decline than hippocampal volume, and that free-water in hippocampus will increase across distinct clinical stages of Alzheimer's disease. We examined two separate cohorts (N = 126; N = 112) of cognitively normal controls, early and late mild cognitive impairment (MCI), and Alzheimer's disease. Demographic, clinical, diffusion-weighted and T1-weighted imaging, and positron emission tomography (PET) imaging were assessed. Results indicated elevated hippocampal free-water in early MCI individuals compared to controls across both cohorts. In contrast, there was no difference in volume of these regions between controls and early MCI. ADNI free-water values in the hippocampus was associated with low CSF AB1–42 levels and high global amyloid PET values. Free-water imaging of the hippocampus can serve as an early stage marker for AD and provides a complementary measure of AD neurodegeneration using non-invasive imaging.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482 · cited 3×
“For the ADNI cohort, a significant group effect was found for all left and right hippocampal ROIs (F's > 9, FDR p .01).”
MethodInfluentialKok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Lee, V. M.-Y., Goedert, M., & Trojanowski, J. Q. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.1121 · Cited by 2,480 · cited 1×
“Further, the pathological changes due to intraneuronal tau or extracellular accumulation of amyloid-β (Aβ) in the hippocampus lead to neuronal shrinkage (Lee et al., 2001), providing greater increase of the extracellular space.”
BackgroundEvaluation of 14 nonlinear deformation algorithms applied to human brain MRI registration
Klein, A., Andersson, J., Ardekani, B. A., Ashburner, J., Avants, B., Chiang, M.-C., Christensen, G. E., Collins, D. L., Gee, J., Hellier, P., et al. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2008.12.037 · Cited by 2,227
Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects
Shaw, L. M., Vanderstichele, H., Knapik‐Czajka, M., Clark, C. M., Aisen, P. S., Petersen, R. C., Blennow, K., Soares, H., Simon, A., Lewczuk, P., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21610 · Cited by 2,065
Free water elimination and mapping from diffusion MRI
Pasternak, O., Sochen, N., Gur, Y., Intrator, N., & Assaf, Y. (2009) · Magnetic Resonance in Medicine · doi:10.1002/mrm.22055 · Cited by 1,092
The Insight ToolKit image registration framework
Avants, B. B., Tustison, N. J., Stauffer, M., Song, G., Wu, B., & Gee, J. C. (2014) · Frontiers in Neuroinformatics · doi:10.3389/fninf.2014.00044 · Cited by 658 · cited 1×
“All maps were warped into standardized space using ANTs R routines (Avants et al., 2008; Avants et al., 2014).”
MethodFellgiebel, A., Wille, P., Müller, M. J., Winterer, G., Scheurich, A., Vucurevic, G., Schmidt, L. G., & Stoeter, P. (2004) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000077817 · Cited by 298 · cited 1×
“Our findings also support the hypothesis that MRI markers of cognitive impairment follow closely with clinical symptoms (Fellgiebel et al., 2004).”
ResultSelective effect of age, Apo e4, and Alzheimer's disease on hippocampal subfields
Mueller, S. G., & Weiner, M. W. (2009) · Hippocampus · doi:10.1002/hipo.20614 · Cited by 248
Cited by
Inflammation and immune dysfunction in Parkinson disease
Tansey, M. G., Wallings, R. L., Houser, M. C., Herrick, M. K., Keating, C. E., & Joers, V. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-022-00684-6 · Cited by 1,382
White matter abnormalities and cognition in aging and Alzheimer disease
Peter, C., Sathe, A., Shashikumar, N., Pechman, K. R., Workmeister, A. W., Jackson, T. B., Huo, Y., Mukherjee, S., Mez, J., Dumitrescu, L. C., et al. (2025) · JAMA Neurology · doi:10.1001/jamaneurol.2025.1601 · Cited by 59
Nakaya, M., Sato, N., Matsuda, H., Maikusa, N., Shigemoto, Y., Sone, D., Yamao, T., Ogawa, M., Kimura, Y., Chiba, E., et al. (2022) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1002/trc2.12356 · Cited by 41
Wang, W.-E., Chen, R., Mayrand, R. P., Adjouadi, M., Fang, R., DeKosky, S. T., Duara, R., Coombes, S. A., & Vaillancourt, D. E. (2023) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.10.013 · Cited by 20
Self-citation
Metadata
- Authors
- Ofori, E., DeKosky, S. T., Febo, M., Colon-Perez, L., Chakrabarty, P., Duara, R., Adjouadi, M., Golde, T. E., & Vaillancourt, D. E.
- Venue
- NeuroImage: Clinical
- Publisher
- Elsevier BV
- Published
- 2019
- Volume
- 24
- Pages
- 101985
- ISSN
- 2213-1582 (ISSN-L)
- OpenAlex
- W2969912298
- Cited by
- 67
- References
- 14
- FWCI
- 4.39
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Free-water imaging of the hippocampus is a sensitive marker of Alzheimer's disease. https://app.cochat.ai/papers/10.1016/j.nicl.2019.101985
- The paper
- Ofori, E., DeKosky, S. T., Febo, M., Colon-Perez, L., Chakrabarty, P., Duara, R., Adjouadi, M., Golde, T. E., & Vaillancourt, D. E. (2019). Free-water imaging of the hippocampus is a sensitive marker of Alzheimer's disease. NeuroImage: Clinical. https://doi.org/10.1016/j.nicl.2019.101985
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.